Increasingly strong reduction in breast cancer mortality due to screening

British Journal of Cancer

Volumn 104, Issue 6, 2011, Pages 910-914

  Van Schoor, G ^a   Moss, S M ^b   Otten, J D M ^a   Donders, R ^a   Paap, E ^a   Den Heeten, G J ^c   Holland, R ^c   Broeders, M J M ^a,c   Verbeek, A L M ^a,c  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c National Expert and Training Centre for Breast Cancer Screening   (Netherlands)

Author keywords

breast cancer; breast cancer mortality; case referent study; screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE; SURVIVAL TIME;

AGED; BREAST NEOPLASMS; CARCINOMA; CASE-CONTROL STUDIES; DOWN-REGULATION; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; PROGRAM EVALUATION;

EID: 79952700269     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2011.44     Document Type: Article

References (42)

1. Allgood PC, Warwick J, Warren RM, Day NE, Duffy SW (2008) A case-control study of the impact of the East Anglian breast screening programme on breast cancer mortality. Br J Cancer 98: 206-209
2. Amir E, Freedman OC, Seruga B, Evans DG (2010) Assessing women at high risk of breast cancer: a review of risk assessment models. J Natl Cancer Inst 102: 680-691
3. Autier P, Boniol M, LaVecchia C, Vatten L, Gavin A, Hery C, Heanue M (2010) Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 341: c3620
4. Becker N, Altenburg HP, Stegmaier C, Ziegler H (2007) Report on trends of incidence (1970-2002) of and mortality (1952-2002) from cancer in Germany. J Cancer Res Clin Oncol 133: 23-35 (Pubitemid 44832777)
5. Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, Mandelblatt JS, Yakovlev AY, Habbema JD, Feuer EJ (2005) Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med 353: 1784-1792 (Pubitemid 41549890)
6. Boyd NF, Guo H, Martin LJ, Sun L, Stone J, Fishell E, Jong RA, Hislop G, Chiarelli A, Minkin S, Yaffe MJ (2007) Mammographic density and the risk and detection of breast cancer. N Engl J Med 356: 227-236 (Pubitemid 46143226)
7. Broeders MJM, Verbeek ALM (2005) Mammographic screening only matters in the detectable preclinical period of breast cancer. J Med Screen 12: 107
8. Demissie K, Mills OF, Rhoads GG (1998) Empirical comparison of the results of randomized controlled trials and case-control studies in evaluating the effectiveness of screening mammography. J Clin Epidemiol 51: 81-91 (Pubitemid 28066134)
9. Duffy SW, Cuzick J, Tabár L, Vitak B, Chen THH, Yen MF, Smith RA (2002) Correcting for non-compliance bias in case-control studies to evaluate cancer screening programmes. J R Statist Soc Ser C Appl Stat 51(Part 2): 235-243
10. Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365: 1687-1717
11. Friedman DR, Dubin N (1991) Case-control evaluation of breast cancer screening efficacy. Am J Epidemiol 133: 974-984
12. Gabe R, Duffy SW (2005) Evaluation of service screening mammography in practice: the impact on breast cancer mortality. Ann Oncol 16(Suppl 2): 153-162
13. Gabe R, Tryggvadottir L, Sigfusson BF, Olafsdottir GH, Sigurdsson K, Duffy SW (2007) A case-control study to estimate the impact of the Icelandic population-based mammography screening program on breast cancer death. Acta Radiol 48: 948-955 (Pubitemid 350022989)
14. Greenland S, Thomas DC (1982) On the need for the rare disease assumption in case-control studies. Am J Epidemiol 116: 547-553
15. Groenwold RH, Nelson DB, Nichol KL, Hoes AW, Hak E (2010) Sensitivity analyses to estimate the potential impact of unmeasured confounding in causal research. Int J Epidemiol 39: 107-117
16. Hellquist BN, Duffy SW, Abdsaleh S, Bjorneld L, Bordas P, Tabar L, Vitak B, Zackrisson S, Nystrom L, Jonsson H (2011) Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort. Cancer 117: 714-722
17. Hendrick RE, Klabunde C, Grivegnee A, Pou G, Ballard-Barbash R (2002) Technical quality control practices in mammography screening programs in 22 countries. Int J Qual Health Care 14: 219-226 (Pubitemid 34679135)
18. Héry C, Ferlay J, Boniol M, Autier P (2008) Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol 19: 1187-1194 (Pubitemid 351796346)
19. Holland R, Rijken H, Hendriks JHCL (2007) The Dutch population-based mammography screening: 30-year experience. Breast Care 2: 12-18 (Pubitemid 46364551)
20. Ichikawa LE, Barlow WE, Anderson ML, Taplin SH, Geller BM, Brenner RJ (2010) Time trends in radiologists' interpretive performance at screening mammography from the community-based Breast Cancer Surveillance Consortium, 1996-2004. Radiology 256: 74-82
21. Jonsson H, Tornberg S, Nystrom L, Lenner P (2000) Service screening with mammography in Sweden-evaluation of effects of screening on breast cancer mortality in age group 40-49 years. Acta Oncol 39: 617-623
22. Jorgensen KJ, Zahl PH, Gotzsche PC (2010) Breast cancer mortality in organised mammography screening in Denmark: comparative study. BMJ 340: c1241
23. Kalager M, Zelen M, Langmark F, Adami HO (2010) Effect of screening mammography on breast-cancer mortality in Norway. N Engl J Med 363: 1203-1210
24. Levi F, Bosetti C, Lucchini F, Negri E, La VC (2005) Monitoring the decrease in breast cancer mortality in Europe. Eur J Cancer Prev 14: 497-502 (Pubitemid 41689648)
25. Miettinen O (1976) Estimability and estimation in case-referent studies. Am J Epidemiol 103: 226-235
26. Moss SM (1991) Case-control studies of screening. Int J Epidemiol 20: 1-6
27. Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L (2009) Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med 151: 727-742
28. Otten JDM, Broeders MJM, Fracheboud J, Otto SJ, de Koning HJ, Verbeek ALM (2008) Impressive time-related influence of the Dutch screening programme on breast cancer incidence and mortality, 1975-2006. Int J Cancer 123: 1929-1934
29. Otten JDM, Van Dijck JAAM, Peer PG, Straatman H, Verbeek ALM, Mravunac M, Hendriks JH, Holland R (1996) Long term breast cancer screening in Nijmegen, the Netherlands: the nine rounds from 1975-92. J Epidemiol Community Health 50: 353-358 (Pubitemid 26237094)
30. Paap E, Holland R, den Heeten GJ, van Schoor G, Botterweck AA, Verbeek ALM, Broeders MJM (2010a) A remarkable reduction of breast cancer deaths in screened versus unscreened women: a case-referent study. Cancer Causes Control 21: 1569-1573
31. Paap E, Verbeek ALM, Puliti D, Paci E, Broeders MJM (2010b) Breast cancer screening case-control study design: impact on breast cancer mortality. Ann Oncol; e-pub ahead of print 5 October 2010, doi:10.1093/annonc/mdq447
32. Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Fajardo LL, Bassett L, D'Orsi C, Jong R, Rebner M (2005) Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353: 1773-1783 (Pubitemid 41549889)
33. Puliti D, Miccinesi G, Collina N, De Lisi V, Federico M, Ferretti S, Finarelli AC, Foca F, Mangone L, Naldoni C, Petrella M, Ponti A, Segnan N, Sigona A, Zarcone M, Zorzi M, Zappa M, Paci E (2008) Effectiveness of service screening: a case-control study to assess breast cancer mortality reduction. Br J Cancer 99: 423-427
34. Rothman KJ, Greenland S, Lash TL (2008) Modern Epidemiology. Wolters Kluwer Health/Lippincott Williams & Wilkins: Philadelphia
35. Schlesselman JJ (1978) Assessing effects of confounding variables. Am J Epidemiol 108: 3-8
36. Shapiro S, Coleman EA, Broeders MJM, Codd MB, de Koning HJ, Fracheboud J, Moss S, Paci E, Stachenko S, Ballard Barbash R (1998) Breast cancer screening programmes in 22 countries: current policies, administration and guidelines. Int J Epidemiol 27: 735-742 (Pubitemid 28504958)
37. Verbeek ALM, Broeders MJM (2010) Evaluation of cancer service screening: case referent studies recommended. Stat Methods Med Res 19: 487-505
38. Verbeek ALM, Hendriks JHCL, Holland R, Mravunac M, Sturmans F, Day NE (1984) Reduction of breast cancer mortality through mass screening with modern mammography. First results of the Nijmegen project, 1975-1981. Lancet 1: 1222-1224 (Pubitemid 14105863)
39. Vervoort MM, Draisma G, Fracheboud J, van de Poll-Franse LV, de Koning HJ (2004) Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality. Br J Cancer 91: 242-247 (Pubitemid 39037066)
40. Weiss NS, McKnight B, Stevens NG (1992) Approaches to the analysis of case-control studies of the efficacy of screening for cancer. Am J Epidemiol 135: 817-823
41. Yaffe MJ, Mainprize JG, Jong RA (2008) Technical developments in mammography. Health Phys 95: 599-611
42. Zahl PH, Maehlen J (2005) Reduction in mortality from breast cancer: decrease with screening was marked in younger age group. BMJ 330: 1024